Virtus Biotech Clinical Trials ETF
11 hedge funds and large institutions have $1.71M invested in Virtus Biotech Clinical Trials ETF in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
82% more capital invested
Capital invested by funds: $940K → $1.71M (+$773K)
22% more funds holding
Funds holding: 9 → 11 (+2)
9.43% more ownership
Funds ownership: 6.7% → 16.13% (+9.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCP
Militia Capital Partners
Las Vegas,
Nevada
|
+$785K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$204K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$202K |
| 4 |
LPL Financial
San Diego,
California
|
+$10.6K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$371K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$175K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$3.34K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MCP
1
Militia Capital Partners
Las Vegas,
Nevada
| $834K | +$785K | +43,193 | New |
|
|
2
LPL Financial
San Diego,
California
| $241K | +$10.6K | +582 | +5% |
|
|
3
UBS Group
Zurich,
Switzerland
| $217K | +$204K | +11,216 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $215K | +$202K | +11,113 | New |
|
5
Morgan Stanley
New York
| $163K | +$200 | +11 | +0.1% |
|
6
US Bancorp
Minneapolis,
Minnesota
| $19.3K | – | – | – |
|
|
DWS
7
Dynamic Wealth Strategies
Granite Bay,
California
| $15.5K | – | – | – |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| $5.86K | +$5.5K | +303 | New |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2.13K | -$3.34K | -184 | -63% |
|
|
AF
10
Allworth Financial
Folsom,
California
| $194 | – | – | – |
|
|
NA
11
NewEdge Advisors
New Orleans,
Louisiana
| $97 | – | – | – |
|
|
12
Jane Street
New York
| – | -$371K | -21,149 | Closed |
|
|
13
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$175K | -10,000 | Closed |
|
BBC Hedge Fund Activity: Q2 2025 in Review
11 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech Clinical Trials ETF (BBC) for Q2 2025, worth a combined $1.71M — up 82% from $940K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BBC positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Militia Capital Partners, opening a new position worth an estimated $785K. The largest seller was Jane Street, exiting entirely with an estimated $371K sold.
- 11 institutional investors held Virtus Biotech Clinical Trials ETF (BBC) as of Q2 2025, up from 9 in Q1 2025.
- Funds reported $1.71M of Virtus Biotech Clinical Trials ETF stock for Q2 2025, up 82% quarter-over-quarter.
- 4 funds opened new Virtus Biotech Clinical Trials ETF positions in Q2 2025 and 2 closed out, a net change of +2 holders.
- The largest Virtus Biotech Clinical Trials ETF buyer in Q2 2025 was Militia Capital Partners, an estimated $785K added.
- The largest Virtus Biotech Clinical Trials ETF seller in Q2 2025 was Jane Street, an estimated $371K sold.
Based on aggregated 13F filings for Q2 2025.